Tetrahydroquinoline derivatives as P2X7 receptor antagonists
US11077100B2 · kind B2 · utility
2Cited by
2References
41Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 13, 2018 |
| Grant date | Aug 3, 2021 |
| Priority date | — |
| Expiry date | Jul 25, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F7/1804
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to tetrahydroquinoline derivatives of the present invention or a pharmaceutically acceptable salt thereof or a prodrug thereof, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders which are mediated via the P2X7 receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.